NANA – Registry-based non-randomized studies for assessing the benefits and harms of drugs
Department of Medical Statistics
The research team in the NANA project is investigating whether it is currently possible and sensible to use the registry data available in Germany for assessing the benefits and harms of new drugs.
For this purpose, the team is carrying out ten to twelve register-based non-randomized studies. The results of these analyses will be compared with the existing results on the same clinical question from randomised controlled trials.
The project aims to provide insights into the circumstances under which an analysis based on routinely collected data can provide reliable results on the benefits and harms of drugs and which aspects need to be carefully considered when such analyses are implemented.
The project is funded by the “Federal Joint Committee”. Find here the project description of the “Innovationsausschuss”.
Contact
contact information
- telephone: +49 551 3964064
- fax: +49 551 3965605
- e-mail address: tim.mathes(at)med.uni-goettingen.de
- location: Humboldtallee 32, EG, 141
contact information
- telephone: +49 551 3963021
- fax: +49 551 3965605
- e-mail address: reginasharon.kampo(at)med.uni-goettingen.de
- location: Humboldtallee 32, E1. Stock, 1.127
contact information
- telephone: +49 551 3961191
- fax: +49 551 3965605
- e-mail address: susanna.salem(at)med.uni-goettingen.de
- location: Humboldtallee 32, EG 162
contact information
- telephone: +49 551 3964992
- fax: +49 551 3965605
- e-mail address: paula.starke(at)med.uni-goettingen.de
- location: Humboldtallee 32, EG, 140